Hepatitis C virus non-structural 3/4A protein interferes with intrahepatic interferon-γ production

被引:18
作者
Brenndorfer, Erwin Daniel [1 ]
Brass, Anette [1 ]
Soderholm, Jonas [2 ,3 ]
Frelin, Lars [1 ]
Aleman, Soo [4 ]
Bode, Johannes Georg [5 ]
Sallberg, Matti [1 ]
机构
[1] Karolinska Inst, Div Clin Microbiol F68, Dept Lab Med, Karolinska Univ Hosp, S-14186 Stockholm, Sweden
[2] Inovio Biomed Corp, San Diego, CA USA
[3] Univ Gothenburg, Dept Infect Dis, Sahlgrenska Acad, Gothenburg, Sweden
[4] Karolinska Univ Hosp Solna, Dept Gastroenterol & Hepatol, Solna, Sweden
[5] Univ Dusseldorf, Dept Gastroenterol Hepatol & Infectiol, Univ Hosp, D-40225 Dusseldorf, Germany
基金
瑞典研究理事会;
关键词
VIRAL CLEARANCE; CHEMOKINE RECEPTORS; CELL RECRUITMENT; ADAPTER PROTEIN; IMMUNE EVASION; T-CELLS; LIVER; INNATE; CXCR3; PERSISTENCE;
D O I
10.1136/gut.2010.232116
中图分类号
R57 [消化系及腹部疾病];
学科分类号
100201 [内科学];
摘要
Background The non-structural (NS) 3/4A protease/helicase of the hepatitis C virus is known to modulate signalling pathways in the infected hepatocyte by cleaving CARD adaptor inducing IFN beta (Cardif), T-cell protein tyrosine phosphatase (TC-PTP) and TIR domain-containing adaptor inducing IFN beta (TRIF), but the effects of NS3/4A in vivo still remain unclear. Aim To investigate the influence of NS3/4A on intracellular and intercellular signalling in vivo by analysing the intrahepatic inflammatory response of naive, lipopolysaccharide (LPS)/D-galactosamine (D-galN) or tumour necrosis factor-alpha (TNF alpha)/D-galN-treated NS3/4A-transgenic (Tg) mice. Methods The intrahepatic immunity of naive and LPS/D-galN-or TNF alpha/D-galN-treated NS3/4A-Tg mice was determined using western blot, ELISA, real-time PCR, flow cytometry and survival monitoring. The injection of cytokines or antibodies against signalling components was performed to analyse the relevance of the respective pathways for the investigated issues. A Tg mouse lineage expressing an inactivated NS3/4A protease (NS3/4A(Ile1073Ala)-Tgs) was generated to examine if protective effects were NS3/4A protease dependent. Results The activation of hepatic signal transducer and activator of transcription 1 and 2 was impaired in NS3/4A-Tg mice after treatment with LPS/D-galN or TNF alpha/D-galN. This was paralleled by a reduction in hepatic interferon-g (IFN gamma). Reconstitution of IFN gamma reverted the resistance to LPS/TNF alpha in NS3/4A-Tg mice. Subsequently, blocking IFNg in vivo rendered wild-type mice resistant against treatment with LPS/TNF alpha. A new Tg mouse expressing an inactivated NS3/4A protease had the same phenotype as wild-type mice with respect to hepatic IFN gamma levels and sensitivity to LPS/D-galN. Finally, the chemokine profile was altered in the NS3/4A-Tg mice towards an anti-inflammatory state, which helps to explain the altered immune cell subsets and reduction in hepatic IFN gamma production. Conclusions Our data demonstrate that the NS3/4A protease reduces the intrahepatic production of IFN Omega and alters TNF alpha-mediated effects, thereby impairing the hepatic inflammatory response. This may contribute to viral persistence.
引用
收藏
页码:589 / 596
页数:8
相关论文
共 41 条
[21]
Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF [J].
Li, K ;
Foy, E ;
Ferreon, JC ;
Nakamura, M ;
Ferreon, ACM ;
Ikeda, M ;
Ray, SC ;
Gale, M ;
Lemon, SM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (08) :2992-2997
[22]
Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity [J].
Li, XD ;
Sun, LJ ;
Seth, RB ;
Pineda, G ;
Chen, ZJJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (49) :17717-17722
[23]
Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296
[24]
CCR5 is characteristic of Th1 lymphocytes [J].
Loetscher, P ;
Uguccioni, M ;
Bordoli, L ;
Baggiolini, M ;
Moser, B .
NATURE, 1998, 391 (6665) :344-345
[25]
The chemokine system: redundancy for robust outputs [J].
Mantovani, A .
IMMUNOLOGY TODAY, 1999, 20 (06) :254-257
[26]
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus [J].
Meylan, E ;
Curran, J ;
Hofmann, K ;
Moradpour, D ;
Binder, M ;
Bartenschlager, R ;
Tschopp, R .
NATURE, 2005, 437 (7062) :1167-1172
[27]
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response [J].
Missale, G ;
Bertoni, R ;
Lamonaca, V ;
Valli, A ;
Massari, M ;
Mori, C ;
Rumi, MG ;
Houghton, M ;
Fiaccadori, F ;
Ferrari, C .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (03) :706-714
[28]
Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus [J].
Nakayama, T ;
Hieshima, K ;
Nagakubo, D ;
Sato, E ;
Nakayama, M ;
Kawa, K ;
Yoshie, O .
JOURNAL OF VIROLOGY, 2004, 78 (04) :1665-1674
[29]
The role of CC chemokine receptor 5 in antiviral immunity [J].
Nansen, A ;
Christensen, JP ;
Andreasen, SO ;
Bartholdy, C ;
Christensen, JE ;
Thomsen, AR .
BLOOD, 2002, 99 (04) :1237-1245
[30]
Cutting edge: Selective usage of chemokine receptors by plasmacytoid dendritic cells [J].
Penna, G ;
Sozzani, S ;
Adorini, L .
JOURNAL OF IMMUNOLOGY, 2001, 167 (04) :1862-1866